The Motley Fool
22 Oct 2026, 02:45 UTC · 1h ago
NVE: 3 Key Takeaways for Long-Term Investors
Impact · against what's priced in
NVEC is seeing strong commercial momentum and product expansion into robotics that offsets temporary delays in medical and defense sectors. The establishment of a revenue floor for the second half of fiscal 2027 provides a concrete baseline for full-year growth expectations.
- NVEC+0.40
No priced-in read yet
- In context
The company reported a 36% increase in revenue for the first half of fiscal 2027 and established a minimum revenue floor of $16.9 million for the second half, signaling a likely full-year revenue of at least $33.8 million.
Read from the article alone
